Research Article| Volume 33, ISSUE 4, P307-309, February 15, 1993

Download started.


An ACTH 4–9 analog (Org 2766) and cognitive performance: High-dose efficacy and safety in dementia of the Alzheimer's type

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Psychiatric Association
        3rd Ed. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Press, Washington, DC1980: 111-112
        • Berry S.
        • Haynes L.W.
        The opiomelanocortin peptide family: Neuronal expression and modulation of neural cellular development and regeneration in the central nervous system.
        Comp Bioch Physiol. 1989; 93: 267-272
        • Branconnier R.J.
        • Cole J.O.
        The effects of Org 2766 on mild senile organic brain syndrome. Unpublished results cited by Pigache RM, Rigter H (1980): Effects of peptides related to ACTH on mood and vigilance in man.
        in: Frontier of Hormone Research. Vol. 6. Karger, Zurich1980
        • Braverman A.
        • Hamdy R.
        • Hendrickson E.
        • Meisner P.
        • Perrera J.
        • Pigache R.M.
        Unpublished results cited by Pigache RM, Rigter H.
        in: Frontier of Hormone Research. Vol. 6. Karger, Zurich1980
        • Buschke H.
        • Fuld P.A.
        Evaluating storage, retention, and retrieval in disordered memory and learning.
        Neurology. 1974; 24: 1019-1025
        • Ferris S.H.
        • Resiberg B.
        • Gershon S.
        Neuropeptide effects on cognition in the elderly.
        in: Poon L. Aging in the 1980's: Selected Contemporary Issues in the Psychology of Aging. American Psychological Association, Washington, DC1980
        • Folstein M.F.
        • Folstein S.E.
        • McHugh P.R.
        “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician.
        J Psychiatr Res. 1975; 12: 189-198
        • Gaillard A.W.K.
        • Varey C.A.
        Some effects of an ACTH 4–9 analog (Org 2766) on human performance.
        Physiol Behav. 1979; 23: 79-84
        • Greven H.M.
        • De Wied D.
        The influence of peptides derived from corticotrophin on performance. Structure-activity studies.
        Progr Brain Res. 1973; 39: 429-442
        • Horowitz S.H.
        Therapeutic strategies in promoting peripheral nerve regeneration.
        Muscle and Nerve. 1989; 12: 314-322
        • Miller T.P.
        • Taylor J.L.
        • Tinklenberg J.R.
        A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics.
        Neuropsychobiology. 1988; 19: 90-96
        • Norris H.
        The action of sedatives on brain stem oculomotor systems in man.
        Neuropharmacology. 1971; 10: 181-191
        • O'Hanlon J.F.
        • Fussler C.
        • Sancin E.
        • Grandjean E.P.
        Efficacy of an ACTH 4–9 analog, relative to that of a standard drug (d-amphetamine) for blocking the “vigilance decrement” in men.
        Report to Organon International. 1978; (October 1978)
        • Pigache R.M.
        • Rigter H.
        Effects of peptides related to ACTH on mood and vigilance in man.
        in: Frontier of Hormone Research. Vol. 6. Karger, Zurich1980
        • Resiberg B.
        • Ferris S.
        • de Leon M.J.
        • Crook T.
        The Global Deterioration Scale (GDS): An instrument for the assessment of primary degenerative dementia (PDD).
        Am J Psychiatry. 1982; 139: 1136-1139
        • Rosen W.
        • Mohs R.
        • Davis K.
        A new rating scale for Alzheimer's disease.
        Am J Psychiatry. 1984; 141: 1356-1364
        • Shakow D.
        Psychological deficit in schizophrenia.
        Behavioral Science. 1963; 8: 275-305
        • Shakow D.
        The Worcester State Hospital research on schizophrenia (1927–1946).
        Journal of Abnormal Psychology. 1972; 80: 67-110
        • Strand F.L.
        • Rose K.J.
        • King J.A.
        • Segarra A.C.
        • Zuccarelli L.A.
        ACTH modulation of nerve development and regeneration.
        Prog Neurobiol. 1989; 33: 45-85
        • Tinklenberg J.R.
        • Taylor J.L.
        Assessments of drug effects on human memory functions.
        in: Squire L.R. Butters N. The Neuropsychology of Memory. Guildford Press, New York1984: 213-223
        • Tinklenberg J.R.
        • Taylor J.L.
        • Miller T.P.
        • Redington D.
        Dual task assessment of attentional capacities in aging and dementia.
        in: Gaitz C.M. Schoolar J.C. Rabinowitz H. Aging 2000: Our Health Care Destiny. Springer Publishing Co, New York1985
        • Van der Hoop R.G.
        • Brakkee J.H.
        • Kapelle A.
        • Samson M.
        • de Koning P.
        • Gispen W.H.
        A new approach for the evaluation of recovery after peripheral nerve damage.
        J Neurosci Methods. 1988; 26: 111-116
        • Willner A.
        Effects of peptides related to ACTH on mood and vigilance in man. Frontier of Hormone Research. Vol. 6. Karger, Zurich1980 (Unpublished results cited by Pigache RM, Rigter H)